Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 26;15(1):39.
doi: 10.1186/s13561-025-00633-8.

Budgetary impact of increasing use of peritoneal dialysis over haemodialysis in Spain

Gemma Barbado  1 , Carla Garí  2 , Asís Ariznavarreta  3 , Neus Vidal-Vilar  3 , Carlos Alvarez  4
Affiliations
Review

Budgetary impact of increasing use of peritoneal dialysis over haemodialysis in Spain

Gemma Barbado et al. Health Econ Rev. .

Abstract

Background: Chronic kidney disease (CKD) represents a significant public health concern, due to its high prevalence and incidence, as well as its substantial socio-economic costs. In Spain, estimates suggest that the direct healthcare costs of CKD will increase by 13.8% from 2022, which is why the cost of kidney replacement treatment (KRT) programs efficiency and sustainability is under constant analysis. Our analysis aimed to estimate the cost associated with peritoneal dialysis (PD) compared to hemodialysis (HD) from the Spanish National Health System (NHS) perspective and to evaluate the budgetary impact of an increase in the use of PD in our healthcare system environment.

Methods: The number of patients eligible for KRT was calculated based on the total Spanish population and the incidence and prevalence of patients with end-stage renal disease (ESRD). Patients receiving each modality, type of dialysis, and location of dialysis were estimated. The annual costs of each dialysis modality were calculated and included the cost of dialysis sessions and additional costs (including the cost of peritoneal and vascular access, hospitalisation costs due to potential complications of dialysis, cost of health care personnel, and cost of health care transport used by patients). Population data and costs (€, 2024) were obtained from the Spanish databases and a nephrologist validated the assumptions. Budget impact analysis assessed the incremental budget impact between the current scenario and the alternative scenario, where 30% of incident patients on scheduled HD would receive PD.

Results: We estimated that in Spain, there are 27,281 prevalent dialysis patients (3,141 receiving PD and 24,140 receiving HD/HDF) and 6,052 incident dialysis patients (1,173 receiving PD and 4,879 HD/HDF). The cost of dialysis amount to €1,555,573,771 (€141,361,374 PD and €1,414,212,397 to HD) in the current scenarios and to €1,540,584,011 (€167,593,157 PD and €1,372,990,854 HD) in the alternative scenario, resulting in a saving of €14,989,760 when 30% of the patients scheduled to receive HD would instead receive PD during the first year.

Conclusions: The increased use of PD in Spain improves the system's efficiency, generating significant savings in the treatment of ESRD patients from the NHS perspective.

Keywords: Budget impact; Costs; Dialysis; Hemodialysis; Kidney replacement treatment; Peritoneal dialysis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: This analysis was sponsored by Baxter S.L. (Spain). Asís Ariznavarreta, Carla Garí and Neus Vidal-Vilar are employees of Outcomes’ 10 (a ProductLife Group Company), who received an honorarium from Baxter S.L. in connection with the development of this manuscript. Gemma Barbado and Carlos Alvarez are employees of Baxter S.L. All authors of the manuscript (GB, CG, AA, NVV, CA) have contributed to the conception and design of the project and to the interpretation of the data; they have participated in the critical review of the intellectual content of the manuscript and have approved the final version presented.

Figures

Fig. 1
Fig. 1
Description of the analysis
Fig. 2
Fig. 2
Cost distribution for PD and HD/HDF
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Wouk N. End-Stage renal disease: medical management. Am Fam Physician. 2021;104(5):493–9. PMID: 34783494. - PubMed
    1. Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global epidemiology of End-Stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98–107. - PMC - PubMed
    1. Sociedad Española de Nefrología. La enfermedad Renal Crónica en España. (2023). Available at https://www.xn--diamundialdelrion-txb.com/wp-content/uploads/2023/03/SEN.... Accessed in January, 2024.
    1. Alcázar Arroyo R, Navarro González JF, Aranda Oliva U, Capel Sánchez M, Cebrián Cuenca A, Lopez-Chicheri B. M. Moreno Barón, S. Pérez Rodríguez, B. Pimentel De Francisco, A. Ortiz Arduan. INSIDE-CKD: predicción epidemiológica y costes asociados a la ERC de 2022 a 2027 en España. Presented at the 53rd National Congress of the Spanish Society Of Nephrology (SEN). 11–13 November 2023, Palma de Mallorca.
    1. Czyzewski L, Sanko-Resmer J, Wyzgal J, Kurowski A. Assessment of health-related quality of life of patients after kidney transplantation in comparison with Hemodialysis and peritoneal Dialysis. Ann Transpl. 2014;19:576–85. - PubMed

LinkOut - more resources